Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts (CMS-10137)

Forms and Documents

Document	Type	Status	Availability
Form CMS-10137 PACE Medicare Part D Application	Form and Instruction	Modified	Available
Form CMS-10137 Solicitation for Application for Medicare Prescription Drug Plan 2027 Contracts	Form and Instruction	Modified	Available
CMS-2025-0571-DRAFT-0002.html.pdf	Public Comments	Uploaded 2025-08-01	Repair queued
CMS-2025-0571-DRAFT-0001.html.pdf	Public Comments	Uploaded 2025-07-31	Repair queued
CMS-10137 - Supporting Statement A_.docx	Supporting Statement A	Uploaded 2025-11-28	Available
CMS 10137 Response to 60 Day Public Comments.pdf	Supplementary Document	Uploaded 2025-11-28	Repair queued
Part_D_Summ_2027 Application Revisions Technical Substantive.pdf	Supplementary Document	Uploaded 2025-11-28	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
43672	Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts	Form and Instruction	Modified	PACE Medicare Part D Application
43672	Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts	Form and Instruction	Modified	Solicitation for Application for Medicare Prescription Drug Plan 2027 Contracts

ICR Details

OMB Control No: 0938-0936	ICR Reference No: 202511-0938-020
Status: Received in OIRA	Previous ICR Reference No: 202410-0938-025
Agency/Subagency: HHS/CMS	Agency Tracking No: CM-CPC
Title: Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts (CMS-10137)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 11/28/2025

	Requested	Previously Approved
Expiration Date	36 Months From Approved	01/31/2028
Responses	402	424
Time Burden (Hours)	1,724	1,809
Cost Burden (Dollars)	0	0

---

Abstract: The Applications for Part D sponsors to offer qualified prescription drug coverage are completed by entities seeking approval to offer Part D benefits under the Medicare Prescription Drug Benefit program established by section 101 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) and is codified in section 1860D of the Social Security Act (the Act).

---

Authorizing Statute(s): PL: Pub.L. 111 - 148 3314 Name of Law: Including cost incurred by AIDS drug assistance programs and Indian Health services
   PL: Pub.L. 111 - 148 3310 Name of Law: Reducing Wasteful dispensing of outpatient drugs in LTC facilities
   PL: Pub.L. 111 - 148 6005 Name of Law: Pharmacy benefit managers transparency requirements
   Statute at Large: 18 Stat. 1860
   PL: Pub.L. 108 - 173 1860D Name of Law: Medicare Prescription Drug Benefit Program
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 36058	07/31/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 54694	11/28/2025
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts	CMS-10137, CMS-10137	Solicitation for Application for Medicare Prescription Drug Plan 2027 Contracts ,   PACE Medicare Part D Application

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	402	424	0	0	-22	0
Annual Time Burden (Hours)	1,724	1,809	0	0	-85	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Overall, the estimated time for completing the prescription drug applications is 1,723.55 hours. This is an 85.6 hour decrease from the estimate of 1,809.68 hours for the 2026 prescription drug application.

---

Annual Cost to Federal Government: $140,000

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Yes

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 11/28/2025

---